New insights into the pathogenesis of inflammatory bowel disease: Transcription factors analysis in bioptic tissues from pediatric patients

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 3, 2011, Pages 271-279

  Pierdomenico, Maria ^a   Stronati, Laura ^a   Costanzo, Manuela ^a   Vitali, Roberta ^a   Di Nardo, Giovanni ^a   Nuti, Federica ^a   Oliva, Salvatore ^a   Cucchiara, Salvatore ^a   Negroni, Anna ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Crohn disease; inflammation; microarray; transcription factors; ulcerative colitis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; AZATHIOPRINE; CORTICOSTEROID; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESALAZINE; METHYLPREDNISOLONE;

ADOLESCENT; ARTICLE; CELL STRAIN CACO 2; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; EX VIVO STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HYPOXIA; LOW DRUG DOSE; MALE; MICROARRAY ANALYSIS; MUCOSA; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; ULCERATIVE COLITIS; UPREGULATION;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFLAMMATION; INTESTINAL MUCOSA; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 79952316793     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182034d08     Document Type: Article

References (41)

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33. (Pubitemid 37328672)
2. Arseneau KO, Tamagawa H, Pizarro TT, et al. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep 2007;9:508-12. (Pubitemid 351795709)
3. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34. (Pubitemid 47123518)
4. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29. (Pubitemid 34851835)
5. Peng SL. Transcription factors in the pathogenesis of autoimmunity. Clin Immunol 2004;10:112-23. (Pubitemid 38296701)
6. Atreya I, Atreya R, Neurath MF. NF-kB in inflammatory bowel disease. J Intern Med 2008;263:591-6.
7. Ghosh S, Hayden MS. New regulators of NF-kB in inflammation. Nat Rev Immunol 2008;8:837-48.
8. Stronati L, Negroni A, Merola P, et al. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease. Inflamm Bowel Dis 2008;14:295-302. (Pubitemid 351441316)
9. Bousvaros A, Morley-Fletcher A, Pensabene L, et al. Research and clinical challenges in paediatric inflammatory bowel disease. Dig Liver Dis 2008;40:32-8. (Pubitemid 350246391)
10. Inflammatory Bowel Disease Group of ESPGHAN. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7.
11. Hyams JS, Mandel F, Ferry GD, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
12. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007;133:423-32. (Pubitemid 47193130)
13. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53. (Pubitemid 43764536)
14. Thomson MR, Xu D, Williams BR. ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med 2009;87:1053-60.
15. Weidemann A, Johnson RS. Biology of HIF-1α. Cell Death Differ 2008;15:621-7.
16. Noble CL, Abbas AR, Cornelius J, et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 2008;57:1398-405.
17. Carey R, Jurickova I, Ballard E, et al. Activation of an IL-6: STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm Bowel Dis 2008;14:446-57. (Pubitemid 351571824)
18. Kader HA, Tchernev VT, Satyaraj E, et al. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Am J Gastroenterol 2005;100:414-23. (Pubitemid 40314529)
19. Lawrence IC, Fiocchi C, Chakravarti S. Ulcerative and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001;10:445-56. (Pubitemid 32181667)
20. Schreiber S, Rosenstiel J, Hampe S, et al. Activation of signal transducer and activator of transcription (STAT)1 in human chronic inflammatory bowel disease. Gut 2002;51:379-85.
21. Yarilina A, Park-Min KH, Antoniv T, et al. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 2008;9:378-87. (Pubitemid 351405107)
22. Monteleone G, Kumberova A, Croft NM, et al. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001;108:601-9. (Pubitemid 32777740)
23. Hungness ES, Luo GJ, Pritts TA, et al. Transcription factors C/EBP-beta and -delta regulate IL-6 production in IL-1beta-stimulated human enterocytes. J Cell Physiol 2002;192:64-70. (Pubitemid 34587388)
24. Ye DZ, Kaestner KH. Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice. Gastroenterology 2009;137:2052-62.
25. Trojanowska M. Ets factors and regulation of the extracellular matrix. Oncogene 2000;18:6464-71. (Pubitemid 32108436)
26. Chen J, Xiao L, Rao JN, et al. JunD represses transcription and translation of the tight junction protein zona occludens-1 modulating intestinal epithelial barrier function. Mol Biol Cell 2008;19:3701-12.
27. Meixner A, Karreth F, Kenner L, et al. JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J 2004;23:1325-35. (Pubitemid 38525004)
28. Kherrouche Z, De Launoit Y, Monté D. Human E2F6 is alternatively spliced to generate multiple protein isoforms. Biochem Biophys Res Commun 2004;317:749-60. (Pubitemid 38481436)
29. Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Immnunol 2009;9:692-702.
30. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kB in hypoxic inflammation. J Physiol 2008;586:4055-9.
31. Rius J, Guma M, Schachtrup C, et al. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008;453:807-12.
32. Litvak V, Ramsey SA, Rust AG, et al. Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 2009;10:437-43.
33. Hai T,Wolfgang CD, Marsee DK, et al. ATF3 and stress responses. Gene Expr 1999;7:321-35. (Pubitemid 29372076)
34. Gilchrist M, Henderson WRJr, Clark AE, et al. Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation. J Exp Med 2008;205:2349-57.
35. Gilchrist M, Thorsson V, Li B, et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006;441:173-8.
36. Hauser CJ, Locke RR, Kao HW, et al. Visceral surface oxygen tension in experimental colitis in the rabbit. J Lab Clin Med 1988;112:68-71.
37. Taylor CT, Colgan SP. Hypoxia and gastrointestinal disease. J Mol Med 2007;85:1295-300. (Pubitemid 50004090)
38. Karhausen J, Furuta GT, Tomaszewski JE, et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004;114:1098-106. (Pubitemid 39578699)
39. Furuta GT, Turner JR, Taylor CT, et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001;193:1027-34. (Pubitemid 32436196)
40. Shah YM, Ito S, Morimura K, et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 2008;134:2036-48.
41. Shih SC, Claffey KP. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 2001;19:19-34. (Pubitemid 32970678)